MPS Powered by Eureka

Current Medicinal Chemistry

ISSN: 0929-8673 (Print)
eISSN: 1875-533X (Online)

Current Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents.
Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important developments relevant to their field.

Special Issues With Active Call for Papers

Submission closes on: Oct 30, 2025
network pharmacology, and/or Mendelian randomization in the discovery of disease mechanisms in drug treatment.

Based on large-scale data and computer technology, network pharmacology explores the interaction network between drug molecules and molecules in vivo, such as targets, pathways, genes, and proteins, as well as the effects of these interactions on drug efficacy, toxicity, metabolism, etc. It provides more accurate and efficient solutions in drug research and development, drug treatment, drug reuse, etc. In the context of precision medicine, the development of targeted drugs is a hot topic. But finding... see more

Submission closes on: Jun 30, 2025
Immunotherapy, gene therapy and big data analysis in Burns, Trauma and Cosmetic Surgery

In the domains of burn, trauma, and plastic surgery, immunotherapy, gene therapy, and big data analysis are demonstrating tremendous potential and application prospects. Patients with burns and traumas frequently encounter severe tissue damage and immune system disorders. Immunotherapy aims to facilitate tissue repair and restoration by modulating the immune system. Gene therapy offers a novel approach for rectifying genetic deficiencies and promoting cell regeneration. Additionally, big data analysis plays a crucial role in these fields.... see more

Submission closes on: May 30, 2025
Pathological mechanisms of acute diseases and pharmacological intervention

The recognition of and response to potentially life-threatening acute diseases such as acute lung injury/acute respiratory distress syndrome, acute myocardial infarction, acute cerebral ischemia, acute nephritic syndrome, infectious diseases and others, is of increasing concern. The majority of therapeutic strategies to improve outcomes have been unsuccessful so far, highlighting the necessity for further research and development of novel effective treatments. This thematic issue focuses on the current advances of studies on the pathological mechanisms of... see more

Submission closes on: Apr 05, 2025
Cutting-Edge Approaches in Kinase Inhibitors: Design, Synthesis, and Computational Insights

This thematic issue is dedicated to exploring cutting-edge approaches in the design, synthesis, and computational analysis of kinase inhibitors, including classical, allosteric, and covalent modulators. The focus will be on innovative methodologies that drive forward the development of these inhibitors through advanced chemical synthesis techniques, detailed mechanistic studies, and computational modeling. Contributions will highlight how these integrated approaches can optimize inhibitor design, improve selectivity, predict drug interactions, and overcome resistance. The issue aims to provide... see more

Submission closes on: Mar 31, 2025
Machine Learning Approaches for Understanding Cancer Drug Resistance, Tumor Microenvironment and Immunotherapy

Although many patients initially respond positively to chemotherapy or targeted therapy, resistance often develops, leading to treatment failure and disease progression. Cancer drug resistance remains a significant challenge in modern oncology, and understanding the underlying mechanisms of resistance is crucial for developing strategies to overcome this phenomenon. Another rapidly evolving field in cancer treatment research is immunotherapy, which harnesses the power of the immune system to recognize and eliminate cancer cells. However, the success of... see more

Submission closes on: Mar 30, 2025
Non-coding RNAs and common neurosurgical conditions: a key to future personalized molecular therapy

Non-coding RNAs (ncRNAs) are a class of RNA molecules that are not translated into protein. Among the ncRNAs, microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) are especially abundant in nervous system and have been shown to be implicated in its development and well as in most common neurosurgical disorders. The development of ncRNA research as a potential therapy for common neurosurgical disorders has been of particular interest. RNA-targeting therapy is promising, because... see more

Submission closes on: Jan 31, 2025
Novel heterocycles and their biological activity

Discovery and development of novel compounds in medicinal chemistry is most often involved with heterocycles. Novel methods for drug design such as molecular modelling, methods for synthesizing new heterocycles such as multicomponent reactions gather new potential for discoveries in this field. Moreover, chemistry of cosmetics as a source for new biologically active compounds is developing very fast. And – last but not least – analytical methods as well as safety assessment of biologically active compounds... see more

Submission closes on: Jan 31, 2025
NEW FRONTIERS IN CANCER TREATMENT

Although a great progress has been performed in tumor treatment, many cancer patients show unfortunately resistance to current antitumor therapies and, in fact, the disease caused 10 million deaths in 2020. This means that in addition to the current antitumor therapies used in clinical practice, the search for new anticancer therapeutic strategies are urgently needed. Tumor cell proliferation, invasion/metastasis, and angiogenesis are crucial mechanisms in tumor progression that must be understood in-depth to explore and... see more

Submission closes on: Dec 31, 2024
Approaches to the treatment of chronic inflammation

Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this critical field. We encourage submissions exploring a wide range of topics, such as disease prevention through inflammation reduction, including the gut microbiome, and lifestyle interventions.... see more

Submission closes on: Dec 31, 2024
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in medicinal chemistry. see more

Submission closes on: Dec 25, 2024
Organ injury, Protection and Interactions: Novel Targets, Drugs and Mechanisms.

Over 300 million surgical procedures are performed worldwide annually, with numbers steadily increasing. Current data indicate that postoperative deaths constitute 7.7% of global mortality, making it the third leading cause of death worldwide. Perioperative organ protection and management are crucial for reducing postoperative complications and organ injury. Anesthetists, surgeons and researchers work collaboratively to mitigate the incidence of perioperative organ injury. Recently, a growing body of basic research has focused on perioperative organ protection and... see more

Submission closes on: Dec 18, 2024
The roles of metalloenzymes in caner progression and theranostics

Metalloproteinases are proteases with metal ions in their active centers and they interact with metal ions via their metal-binding domains containing amino acid residues arginine, lysine, aspartate, glutamate, histidine. Currently, more than 50 families of metalloproteinases have been found and they are involved in a wide variety of physiological and pathological processes via facilitating matrix degradation, regulating blood pH, and mediating gene transcription. In particular, numerous metalloproteinases are able to directly or indirectly regulate the... see more

Submission closes on: Nov 27, 2024
Current Advances and Future Perspectives of Small Molecule Targeted Therapy in Cancer Treatment

Nowadays, small molecule targeted therapy has emerged as a promising avenue for the treatment of cancer, offering the potential for enhanced efficacy and reduced toxicity compared to traditional chemotherapy. Targeted small molecule drugs specifically act on key molecules involved in cancer progression to interfere with specific signaling pathways that drive tumor growth and survival, thereby offering a more precise and personalized approach to cancer treatment. Currently, a range of small molecules have been approved for... see more

Submission closes on: Nov 19, 2024
Innate immunity disorders in non-infectious inflammatory diseases

Inflammation accompanies all human diseases. Undoubtedly, the inflammatory response is vital for eliminating foreign microorganisms from body tissues and fluids. Also, the immune system is able to recognize and remove not only the infection, but also its own molecules and cells, which for any reason may threaten the health of the body. These include destroyed cells, cancer cells, apoptotic bodies, as well as modified molecules, such as modified low-density lipoproteins, amyloids, lipofuscin and many others.... see more

Submission closes on: Nov 10, 2024
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize and investigate the pathogenesis and clinical implications of various physiological processes, pathology and disease associated with chronic inflammation are welcome. Chronic inflammation is a key... see more

Submission closes on: Oct 23, 2024
Revolutionizing Antimicrobial Drug Discovery: Harnessing AI for Compound Screening

In the relentless pursuit of combating antimicrobial resistance, a groundbreaking AI-based screening system emerges as a pivotal tool in revolutionizing drug discovery. Traditional methods, plagued by their sluggish pace and exorbitant costs, stand overshadowed by this innovative approach poised to expedite the identification of potent antimicrobial compounds. This proposal, enhanced with the power of machine learning and computational methodologies, carefully analyzes extensive datasets of chemical structures and biological activities. By skillfully utilizing advanced algorithms like... see more

Submission closes on: Sep 30, 2024
Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in such modified nucleic acid analogues reflects the ongoing exploration of their numerous applications in various scientific disciplines, from fundamental studies on the structure and function... see more

Submission closes on: Sep 02, 2024
Using disease models for mechanistic studies: special focus on gene editing

The Special Issue is dedicated to utilizing disease models for in-depth mechanistic studies, a fundamental approach in biomedical research that grants us a deeper comprehension of the underlying mechanisms and pathways involved in the development and progression of various diseases. Disease models act as invaluable tools for investigating the causes, interactions, and processes associated with specific health conditions. These models encompass a wide range, from cellular and animal models to patient-derived samples, tailored to the... see more

Submission closes on: Aug 31, 2024
Sports Medicine & Medicinal Chemistry (SMMC)

Sports medicine is an interdisciplinary subject that combines sports with rehabilitation medicine, preventive medicine, laboratory medicine, etc., and it is an interdisciplinary subject integrating basic and clinical disciplines. Research on medical chemistry issues related to sports medicine, including energy distribution and material metabolism in the process of sports training and sports promoting health, is of great significance to reveal the internal mechanism of sports medicine and improve the effect of sports medicine. Sports medicine is... see more

Submission closes on: Jul 31, 2024
Exploring New Targets against Neglected Tropical Diseases and Other Parasites

Neglected Tropical Diseases are a group of infectious diseases that affect a large part of the world's population. These diseases mainly affect people who live in poverty and without basic sanitation, causing severe damage to their health. Diseases caused by Trypanosomatids, such as Chagas disease, sleeping sickness, and leishmaniasis, are among the main ones related to higher mortality rates, especially in Latin America, Africa, and several regions of Asia. In addition, viral diseases such as... see more

Submission closes on: Jul 31, 2024
Drug-Resistant Infections: A Global Challenge for Future

Infections caused by drug resistance occur when pathogens evolve in ways that render antimicrobial drugs ineffective. Pathogens survive and continue to proliferate as a result. When infections are treatable with antimicrobials, individuals can be cured, and further population-wide dissemination can be easily contained. Since widespread use of these "miracle drugs" began more than 70 years ago, this has saved hundreds of millions of lives. Loss of drug efficacy due to antimicrobial resistance (AMR) is on... see more

Submission closes on: Jul 15, 2024
Interdisciplinary Frontiers in Medicinal Chemistry: Nanomedicine, Photodynamic Therapy, and Computational Drug Design

This special issue aims to showcase the synergies between nanomedicine, photodynamic therapy, and computational drug design within the broader scope of medicinal chemistry. The issue will cover advancements in nanocarrier-based drug delivery systems, innovative applications of photodynamic therapy using fluorescent probes, and the integration of computational methodologies for drug discovery. see more